News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

FDA Reviewers: Sanofi (France) (SAN.PA)'s Allergy Drug Can Go OTC


7/30/2013 7:31:35 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Sanofi SA's allergy drug Nasacort AQ is safe enough to be used without a prescription, according to reviewers for the U.S. Food and Drug Administration. The reviewers, whose opinions were posted on the FDA's website on Monday, said the nasal spray, which currently requires a prescription, "has a favorable risk-benefit profile" for over-the-counter use. An advisory committee to the FDA is to decide on Wednesday whether to recommend making Nasacort AQ an over-the-counter product.

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters
Read at Huffington Post
Read at News Release
Read at Wall Street Journal


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES